On Friday, Roivant Sciences Ltd (NASDAQ: ROIV) was 0.56% up from the session before settling in for the closing price of $10.74. A 52-week range for ROIV has been $8.24 – $13.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 493.24%. When this article was written, the company’s average yearly earnings per share was at -119.86%. With a float of $488.34 million, this company’s outstanding shares have now reached $806.68 million.
Let’s determine the extent of company efficiency that accounts for 908 employees.
Roivant Sciences Ltd (ROIV) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Roivant Sciences Ltd stocks. The insider ownership of Roivant Sciences Ltd is 33.89%, while institutional ownership is 60.24%. The most recent insider transaction that took place on Feb 09 ’24, was worth 1,058,694. In this transaction President & COO of this company sold 96,950 shares at a rate of $10.92, taking the stock ownership to the 532,207 shares. Before that another transaction happened on Jan 02 ’24, when Company’s 10% Owner sold 3,000,000 for $11.05, making the entire transaction worth $33,150,000. This insider now owns 51,929,426 shares in total.
Roivant Sciences Ltd (ROIV) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 3/31/2024, it has been observed that the corporation posted -0.38 earnings per share (EPS) during the time that was less than consensus figure (set at -0.3) by -0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -119.86% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
You can see what Roivant Sciences Ltd (ROIV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 25.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 63.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.07, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Looking closely at Roivant Sciences Ltd (NASDAQ: ROIV), its last 5-days average volume was 3.34 million, which is a drop from its year-to-date volume of 5.93 million. As of the previous 9 days, the stock’s Stochastic %D was 10.10%. Additionally, its Average True Range was 0.29.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 50.98%, which indicates a significant increase from 14.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.87% in the past 14 days, which was lower than the 32.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.89, while its 200-day Moving Average is $10.54. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $10.99. Second resistance stands at $11.19. The third major resistance level sits at $11.30. If the price goes on to break the first support level at $10.68, it is likely to go to the next support level at $10.57. Now, if the price goes above the second support level, the third support stands at $10.37.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
There are 738,722K outstanding shares of the company, which has a market capitalization of 7.98 billion. As of now, sales total 124,800 K while income totals 4,349 M. Its latest quarter income was 28,930 K while its last quarter net income were -151,120 K.
